Overview
Tata Memorial Hospital in Mumbai is India's foremost comprehensive cancer centre and one of the leading oncology institutions in Asia. Established in 1941 by the Sir Dorabji Tata Trust, the hospital operates as a grant-in-aid institution under the Department of Atomic Energy, Government of India. It functions as both a treatment centre and a research institute, with Tata Memorial Centre encompassing the hospital and the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC).
The hospital treats over 70,000 new cancer patients annually across all major oncology disciplines including surgical oncology, medical oncology, radiation oncology, haematology, bone marrow transplantation, paediatric oncology, and nuclear medicine. Its infrastructure includes state-of-the-art linear accelerators, brachytherapy units, PET-CT scanners, advanced molecular diagnostics laboratories, and dedicated bone marrow transplant units. Tata Memorial's multidisciplinary tumour boards, disease management groups, and active clinical trial programmes ensure that patients receive treatment aligned with the latest global evidence and protocols.
International patients seeking world-class cancer care at a fraction of Western costs find Tata Memorial Hospital an unmatched destination. The hospital's international patient services division assists with appointment scheduling, medical visa documentation, treatment planning, and accommodation referrals. Despite high patient volumes, the hospital's clinical outcomes in many cancer types are comparable to premier global centres, making it one of the most respected and trusted names in cancer care worldwide.
Awards & Milestones
India's #1 Cancer Hospital — Outlook-ICARE Rankings 2024
WHO Collaborating Centre for Cancer
Government of India Centre of Excellence in Oncology
NABH Accredited
Best Cancer Research Institute — ICMR
Procedures & Specialties at Tata Memorial Hospital Mumbai, India
Head & neck, breast, GI, thoracic, orthopedic, neuro, uro-oncology, gynae-oncology
- Whipple Procedure
- Radical Mastectomy
- Pelvic Exenteration
- Limb Salvage Surgery
Chemotherapy, immunotherapy, targeted therapy, CAR-T cell therapy, clinical trials
- Chemotherapy Protocols
- Immunotherapy (PD-1/PD-L1)
- CAR-T Cell Therapy
- Targeted Molecular Therapy
IMRT, IGRT, SRS, SBRT, brachytherapy, proton therapy, CyberKnife
- CyberKnife Radiosurgery
- IMRT/IGRT
- Stereotactic Radiosurgery
- Brachytherapy
Autologous and allogeneic stem cell transplant for leukemia, lymphoma, myeloma
- Autologous BMT
- Allogeneic BMT
- Haploidentical Transplant
- CAR-T Therapy
Comprehensive childhood cancer care — leukemia, brain tumours, solid tumours
- Pediatric Leukemia Treatment
- Wilms Tumour Surgery
- Neuroblastoma Treatment
- Retinoblastoma Care
PET-CT, radioiodine therapy, theranostics, PSMA therapy for prostate cancer
- PET-CT Imaging
- Radioiodine Therapy
- Lu-177 PSMA Therapy
- Gallium-68 Scanning
Treatments that help the immune system fight cancer.
- Checkpoint Inhibitors
- CAR-T Cell Therapy Guidance
- Cancer Vaccines
- Immunotherapy Monitoring
Treatment matched to the genetic profile of the tumour.
- Tumour Genomic Profiling
- Liquid Biopsy
- Targeted Drug Selection
- Hereditary Cancer Testing
Treatment of leukaemia, lymphoma and myeloma.
- Leukaemia Treatment
- Lymphoma Treatment
- Multiple Myeloma Care
- Blood Disorder Management
Diagnosis and complete treatment of breast cancer.
- Breast-Conserving Surgery
- Mastectomy & Reconstruction
- Sentinel Node Biopsy
- Breast Cancer Screening
Treatment of mouth, throat, larynx and thyroid cancers.
- Oral Cancer Surgery
- Laryngeal Cancer Treatment
- Thyroid Cancer Surgery
- Speech & Swallow Rehabilitation
Treatment of ovarian, uterine and cervical cancers.
- Ovarian Cancer Surgery
- Cervical Cancer Treatment
- Uterine Cancer Surgery
- Fertility-Sparing Options
